Alexander Staus
Dreieich, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of fibrinogen concentrate (BT524) in severe hemorrhage: Phase 3 subcohort analysis of the AdFIrst trial in patients undergoing cytoreductive surgery for pseudomyxoma peritonei.
Journal: Journal of clinical anesthesia
Published: December 15, 2025
Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial.
Journal: EClinicalMedicine
Published: February 17, 2025
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID).
Journal: European journal of medical research
Published: April 15, 2024
The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial.
Journal: Critical care (London, England)
Published: September 11, 2023
Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis.
Journal: Frontiers in pediatrics
Published: June 12, 2023
Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis.
Journal: Life (Basel, Switzerland)
Published: January 25, 2022
Long-term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 15, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026